GILD touts "topline results from an interim analysis"

The stock had a nice pop following this press release, and chatter in the media. Wonder when the “JCs” were selling stock?

Gilead’s Twice-Yearly Lenacapavir Demonstrated 100% Efficacy and Superiority to Daily Truvada® for HIV Prevention

Since you asked. Gilead insider activity:

                  3mon     12mon
# shares bought  11.6K    473.3K
# shares sold    12.9K    252.5K

DB2

1 Like

Thanks. Only one sale after the press release, and that for a puny 2000 shares.

Steve

FWIW, insider buys are a more useful gauge of future price action than sells. There are a lot of reasons to sell but only one reason to buy.

DB2

2 Likes